Federal Register / Vol. 72, No.
153 / Thursday, August 9, 2007 / Notices
basic classes of controlled substances
listed in schedule II:
Drug
Lisdexamfetamine (1205) .............
Remifentanil (9739) ......................
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a). Any
such comments or objections being sent
via regular mail should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537; or any
being sent via express mail should be
sent to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 9, 2007.
Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15499 Filed 8–8–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated April 17, 2007 and
published in the Federal Register on
April 30, 2007, (72 FR 21298), Noramco
Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Drug
Raw Opium (9600) .......................
Concentrate of Poppy Staw
(9670).
The company plans to import the
mstockstill on PROD1PC66 with NOTICES
listed controlled substances to
manufacture other controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
VerDate Aug<31>2005 18:25 Aug 08, 2007 Jkt 211001
44861
and determined that the registration of
Noramco, Inc. to import the basic
classes of controlled substances is
Schedule consistent with the public interest and
with United States obligations under
II international treaties, conventions, or
II
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Noramco, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: August 1, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15514 Filed 8–8–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated May 10, 2007 and
published in the Federal Register on
May 18, 2007, (72 FR 28077), Penick
Corporation, 33 Industrial Park Road,
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Drug
Coca Leaves (9040) .....................
Raw Opium (9600) .......................
Poppy Straw (9650) .....................
Concentrate of Poppy Straw
(9670).
Schedule
The company plans to import the
II listed controlled substances to
II manufacture bulk controlled substance
intermediates for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in Title 21, United States Code
(U.S.C.) § 823(a) and § 952(a) and
determined that the registration of
Penick Corporation to import the basic
classes of controlled substances is
consistent with the public interest and
PO 00000 Frm 00043 Fmt 4703 Sfmt 4703
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Penick
Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to Title 21, U.S.C.
952(a) and 958(a), and in accordance
with Title 21, Code of Federal
Regulations (CFR) § 1301.34, the above
named company is granted registration
as an importer of the basic classes of
controlled substances listed.
Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15515 Filed 8–8–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 9, 2007, and
published in the Federal Register on
March 23, 2007 (72 FR 13825), Sigma
Aldrich Research, Biochemicals, Inc., 1–
3 Strathmore Road, Natick,
Massachusetts 01760, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I:
Drug Schedule
Psilocybin (7437) .......................... I
Schedule 5-Methoxy-N,N- I
diisopropyltyptamine (7439).
II
II
II The company plans on manufacturing
reference standards for research
II
purposes only.
No comments or objections have been
received. DEA has considered the
factors in Title 21, United States Code
(U.S.C.) 823(a) and determined that the
registration of Sigma Aldrich Research,
Biochemicals, Inc. to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Sigma
Aldrich Research, Biochemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
E:\FR\FM\09AUN1.SGM 09AUN1